Anteris Technologies Global Corp (AU:AVR) — Market Cap & Net Worth
Market Cap & Net Worth: Anteris Technologies Global Corp (AVR)
Anteris Technologies Global Corp (AU:AVR) has a market capitalization of $822.33 Million (AU$1.16 Billion) as of September 17, 2026. Listed on the AU stock exchange, this Australia-based company holds position #9781 globally and #245 in its home market, demonstrating a -1.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anteris Technologies Global Corp's stock price AU$12.00 by its total outstanding shares 96849743 (96.85 Million). Also see AVR asset base for a full breakdown of the balance sheet.
Anteris Technologies Global Corp Market Cap History: 2015 to 2026
Anteris Technologies Global Corp's market capitalization history from 2015 to 2026. Data shows change from $4.69 Billion to $822.33 Million (-14.46% CAGR). Also see AVR cash generation efficiency for how efficiently the company converts equity into cash flow.
Anteris Technologies Global Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anteris Technologies Global Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Anteris Technologies Global Corp for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
129.77x
Anteris Technologies Global Corp's market cap is 129.77 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.69 Billion | $14.15 Million | -$24.01 Million | 331.73x | N/A |
| 2016 | $2.47 Billion | $22.32 Million | -$12.31 Million | 110.51x | N/A |
| 2017 | $2.02 Billion | $22.61 Million | -$17.26 Million | 89.41x | N/A |
| 2018 | $424.87 Million | $25.60 Million | -$24.22 Million | 16.60x | N/A |
| 2019 | $685.27 Million | $17.08 Million | -$5.82 Million | 40.13x | N/A |
| 2020 | $256.98 Million | $7.08 Million | -$15.27 Million | 36.30x | N/A |
| 2021 | $888.11 Million | $7.79 Million | -$22.91 Million | 113.99x | N/A |
| 2022 | $1.52 Billion | $4.59 Million | -$44.34 Million | 331.44x | N/A |
| 2023 | $1.31 Billion | $4.11 Million | -$67.33 Million | 319.21x | N/A |
| 2024 | $566.72 Million | $4.37 Million | -$123.26 Million | 129.77x | N/A |
Competitor Companies of AVR by Market Capitalization
Companies near Anteris Technologies Global Corp in the global market cap rankings as of September 17, 2026. Review Anteris Technologies Global Corp (AVR) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Anteris Technologies Global Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Anteris Technologies Global Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Anteris Technologies Global Corp's market cap moved from $4.69 Billion to $ 822.33 Million, with a yearly change of -14.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$822.33 Million | +56.66% |
| 2025 | AU$524.92 Million | -7.38% |
| 2024 | AU$566.72 Million | -56.81% |
| 2023 | AU$1.31 Billion | -13.74% |
| 2022 | AU$1.52 Billion | +71.30% |
| 2021 | AU$888.11 Million | +245.60% |
| 2020 | AU$256.98 Million | -62.50% |
| 2019 | AU$685.27 Million | +61.29% |
| 2018 | AU$424.87 Million | -78.98% |
| 2017 | AU$2.02 Billion | -18.06% |
| 2016 | AU$2.47 Billion | -47.45% |
| 2015 | AU$4.69 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Anteris Technologies Global Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $822.33 Million USD |
| MoneyControl | $822.33 Million USD |
| MarketWatch | $822.33 Million USD |
| marketcap.company | $822.33 Million USD |
| Reuters | $822.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anteris Technologies Global Corp
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more